Cargando…
Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors
Emerging evidence indicates that alternative splicing plays a critical role in cancer progression through abnormal expression or mutation of splicing factors. Small-molecule splicing modulators have recently attracted considerable attention as a novel class of cancer therapeutics. CDC-like kinases (...
Autores principales: | Murai, Aiko, Ebara, Shunsuke, Sasaki, Satoshi, Ohashi, Tomohiro, Miyazaki, Tohru, Nomura, Toshiyuki, Araki, Shinsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567398/ https://www.ncbi.nlm.nih.gov/pubmed/33064779 http://dx.doi.org/10.1371/journal.pone.0240718 |
Ejemplares similares
-
Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing
por: Araki, Shinsuke, et al.
Publicado: (2015) -
CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor
por: Funnell, Tyler, et al.
Publicado: (2017) -
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4
por: Tiek, Deanna, et al.
Publicado: (2023) -
Controlling clots with Clk1
por: Williams, Ruth
Publicado: (2006) -
Benzobisthiazoles Represent a Novel Scaffold for Kinase
Inhibitors of CLK Family Members
por: Prak, Krisna, et al.
Publicado: (2015)